Which telehealth services still offer compounded GLP-1s after the FDA crackdown?

Short answer: I can’t give a reliable, up‑to‑the‑minute list of which telehealth companies are still offering compounded GLP‑1 products — availability changed rapidly after the FDA warnings and many reputable services stopped compounding for safety and liability reasons. If your goal is safe access to these medicines, it’s better to look for telehealth providers that prescribe FDA‑approved GLP‑1 drugs and fill through verified specialty pharmacies rather than seek compounded versions.

What I can recommend

• Telehealth companies that commonly handle GLP‑1 prescriptions (and generally route prescriptions to verified pharmacies or specialty pharmacies rather than compounding pharmacies): Hims & Hers, Ro (Roman), PlushCare, GoodRx Care / Balance, and One Medical. These vendors will usually prescribe FDA‑approved branded products (e.g., semaglutide or tirzepatide brands) when clinically appropriate.
• Large specialty pharmacies that dispense FDA‑approved GLP‑1 injectables (safer than unregulated compounded products): CVS Specialty, Walgreens Specialty Pharmacy, Optum/Accredo, and AllianceRx Walgreens Prime.

Why this approach

• The FDA’s concerns about compounded GLP‑1s center on inconsistent potency, sterility, and lack of oversight. Using a telehealth service that prescribes FDA‑approved products filled by a major specialty pharmacy reduces those risks.
• Many smaller telehealth + compounding pharmacy combos that previously offered inexpensive compounded semaglutide/tirzepatide withdrew from the market after enforcement and safety alerts.

How to verify before you buy

1. Ask the telehealth clinician what exactly they are prescribing: brand name and strength (e.g., Wegovy, Ozempic, Mounjaro, Zepbound) or whether it’s a compounded formulation.
2. Ask the pharmacy name and whether the product has an NDC, manufacturer, lot number, and expiration date. FDA‑approved products will have an NDC and manufacturer listed.
3. If it’s a compounded product, ask for the compounding pharmacy’s state license, USP <797>/<800> compliance, and whether the pharmacy is accredited (e.g., PCAB). Be cautious if questions aren’t answered.
4. Consider filling through a major specialty pharmacy or your retail pharmacy chain to avoid unknown compounding sources.

Safety/legal note

• The FDA has warned against many compounded GLP‑1 products. If you buy a compounded product and have an adverse event, report it to FDA MedWatch and to your clinician.
• Discuss alternatives with a licensed clinician — in many cases an FDA‑approved GLP‑1 from a specialty pharmacy is the safer option.

If you want, tell me the specific telehealth service(s) you’re looking at and I’ll help you check whether they advertise compounded products or how to confirm what they supply.